Subscribe

What are you looking for?

Main Menu

明報新聞網

同源康醫藥伙齊魯開發藥物 向後者配股集資4億

Future Wealths
Future Wealths
21 7 月, 2026
One Min Read
1 Views
0 Comments
同源康醫藥（2410）公布，與齊魯製藥達成許可及合作協議，共同推進旗下藥物TY-9591在中國的開發、生產及商業化。公司將收取合共約7億元人民幣的首付款，其中包括認購協議項下的約4億元，另有潛在里程碑付款。

原文: https://finance.mingpao.com/fin/instantf/20260721/1784634705918/%E5%90%8C%E6%BA%90%E5%BA%B7%E9%86%AB%E8%97%A5%E4%BC%99%E9%BD%8A%E9%AD%AF%E9%96%8B%E7%99%BC%E8%97%A5%E7%89%A9-%E5%90%91%E5%BE%8C%E8%80%85%E9%85%8D%E8%82%A1%E9%9B%86%E8%B3%874%E5%84%84%22%20target=%22blank

Last Update: 21 7 月, 2026

Please share this article if you like it!

Link Copied!
Future Wealths
Written By

Future Wealths

Other Articles

Related Posts

Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.

Accept